Shanghai Allist Pharmaceuticals Co (SHSE:688578) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688578 Shanghai Allist Pharmaceuticals Co Ltd SHSE:688578
80 GF Score
Price ¥111.20
GF Value ¥135.47
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Allist Pharmaceuticals Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Shanghai Allist Pharmaceuticals Co Valuation Rank Related Terms

SHSE:688578
80GF Score
Shanghai Allist Pharmaceuticals Co Ltd SHSE:688578
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Allist Pharmaceuticals Co (SHSE:688578) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Allist Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥111.20 is trading 17.9% below its estimated GF Value™ of ¥135.47. GuruFocus considers Shanghai Allist Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for SHSE:688578:

  • Valuation Rank:
  • GF Value™: ¥135.47 vs. price of ¥111.20 (17.9% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Allist Pharmaceuticals Co Business Description

Address 1118 HaLei Road & 1227 ZhangHeng Road, Building 1, 5th Floor, ZhangJiang Hi-Tech Park, PuDong District, Shanghai, CHN, 201203
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.
80GF Score

Get the complete analysis for SHSE:688578

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥111.20
Price
¥135.47
GF Value